Back to search

Article

A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance

2021-05-05

Abstract excerpt

More than one year into a global pandemic, SARS-CoV-2 is now defined by a variety of rapidly evolving variant lineages. Several FDA authorized molecular diagnostic tests have been impacted by viral variation, while no reports of viral variation affecting antigen test performance have occurred to date. While determining the analytical sensitivity of the Quidel Sofia SARS Antigen FIA test (Sofia 2), we uncovered a h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bac6a073-9940-5427-a5a7-b6ba99a09ea5
DOI
10.1101/2021.05.05.21256527
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test PerformanceDOI 10.1101/2021.05.05.21256527
Select a neighboring publication to make it the new centre.